Cancer Biomarkers

SJR Rank #10,354H-index: 60SJR: 0.572Best quartile: Q2
Journal website: aims, scope and author guidelines
Publisher

SAGE Publications Ltd

Country

United Kingdom

Type

journal

SJR by Edition

2022202500.20.40.60.8

Subject Categories

  • Medicine (miscellaneous)Q2
  • Cancer ResearchQ3
  • GeneticsQ3
  • OncologyQ3

Areas: Biochemistry, Genetics and Molecular Biology · Medicine

Most published research topics

MicroRNA in disease regulationCancer-related molecular mechanisms researchCircular RNAs in diseasesFerroptosis and cancer prognosisEpigenetics and DNA MethylationRNA modifications and cancerCancer Cells and MetastasisInflammatory Biomarkers in Disease PrognosisLung Cancer Treatments and MutationsCancer Immunotherapy and Biomarkers

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs080160240320

Documents per Year

2022202503570105140

Detailed Information

ISSN

1574-0153, 1875-8592

SJR Best Quartile

Q2

Region

Western Europe

Citations per Document (2 years)

1.81

References per Document

0.00

Coverage

2005-2025

Scope

Concentrating on molecular biomarkers in cancer research, Cancer Biomarkers publishes original research findings (and reviews solicited by the editor) on the subject of the identification of markers associated with the disease processes whether or not they are an integral part of the pathological lesion. The disease markers may include, but are not limited to, genomic, epigenomic, proteomics, cellular and morphologic, and genetic factors predisposing to the disease or indicating the occurrence of the disease. Manuscripts on these factors or biomarkers, either in altered forms, abnormal concentrations or with abnormal tissue distribution leading to disease causation will be accepted.

Metrics from SCImago Journal Rank 2025. View on SCImago